Mehran, R. et al.  (2022)  The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial.   Circulation, 146(23),  pp. 1749-1757.   (doi: 10.1161/CIRCULATIONAHA.122.060841) (PMID:36321459)